Clopidogrel in acute coronary syndromes

被引：7
|
作者：
Chua, Doson [1 ]
Ignaszewski, Andrew [1 ]
机构：
[1] St Pauls Hosp, Dept Pharm, Div Cardiol, Vancouver, BC V6Z 1Y6, Canada
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2009年 / 338卷
关键词：
ASSOCIATION TASK-FORCE; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; HEART-ASSOCIATION; AMERICAN-COLLEGE; CARDIOVASCULAR ANGIOGRAPHY; WRITING COMMITTEE; EUROPEAN-SOCIETY; ASPIRIN; INTERVENTION;
D O I：
10.1136/bmj.b1180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：998 / 1002
页数：8
相关论文
共 50 条
  • [21] Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
    Roe, Matthew T.
    Armstrong, Paul W.
    Fox, Keith A. A.
    White, Harvey D.
    Prabhakaran, Dorairaj
    Goodman, Shaun G.
    Cornel, Jan H.
    Bhatt, Deepak L.
    Clemmensen, Peter
    Martinez, Felipe
    Ardissino, Diego
    Nicolau, Jose C.
    Boden, William E.
    Gurbel, Paul A.
    Ruzyllo, Witold
    Dalby, Anthony J.
    McGuire, Darren K.
    Leiva-Pons, Jose L.
    Parkhomenko, Alexander
    Gottlieb, Shmuel
    Topacio, Gracita O.
    Hamm, Christian
    Pavlides, Gregory
    Goudev, Assen R.
    Oto, Ali
    Tseng, Chuen-Den
    Merkely, Bela
    Gasparovic, Vladimir
    Corbalan, Ramon
    Cinteza, Mircea
    McLendon, R. Craig
    Winters, Kenneth J.
    Brown, Eileen B.
    Lokhnygina, Yuliya
    Aylward, Philip E.
    Huber, Kurt
    Hochman, Judith S.
    Ohman, E. Magnus
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14): : 1297 - 1309
  • [22] Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes
    Varenhorst, Christoph
    Alstrom, Ulrica
    Braun, Oscar O.
    Storey, Robert F.
    Mahaffey, Kenneth W.
    Bertilsson, Maria
    Cannon, Christopher P.
    Scirica, Benjamin M.
    Himmelmann, Anders
    James, Stefan K.
    Wallentin, Lars
    Held, Claes
    HEART, 2014, 100 (22) : 1762 - +
  • [23] The Role of Clopidogrel in Revascularized and Nonrevascularized Patients with Acute Coronary Syndromes
    J. Stewart Collins
    Hitinder S. Gurm
    American Journal of Cardiovascular Drugs, 2007, 7 : 159 - 168
  • [24] Defining the optimal dose of aspirin and clopidogrel in acute coronary syndromes
    Gurm, Hitinder S.
    Eagle, Kim A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (01) : 148 - 150
  • [25] Acetylsalicylic acid and clopidogrel hyporesponsiveness following acute coronary syndromes
    Tantry, Udaya S.
    Navarese, Eliano P.
    Bliden, Kevin P.
    Gurbel, Paul A.
    KARDIOLOGIA POLSKA, 2018, 76 (09) : 1312 - 1319
  • [26] CLOPIDOGREL RESISTANCE - RISK FACTOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES
    Costache, Irina Iuliana
    Rusu, Cristina
    Ivanov, I.
    Popescu, Roxana
    Petris, A.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (02): : 383 - 388
  • [27] Early and late effects of clopidogrel in patients with acute coronary syndromes
    Yusuf, S
    Mehta, SR
    Zhao, F
    Gersh, BJ
    Commerford, PJ
    Blumenthal, M
    Budaj, A
    Wittlinger, T
    Fox, KAA
    CIRCULATION, 2003, 107 (07) : 966 - 972
  • [28] Pharmacotherapy of acute coronary syndromes: Medical economics with an emphasis on clopidogrel
    Bramkamp, M
    Dedes, KJ
    Szucs, TD
    CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (04) : 291 - 299
  • [29] Suboptimal response to clopidogrel and the effect of prasugrel in acute coronary syndromes
    Johnston, L. R.
    Larsen, P. D.
    La Flamme, A. C.
    Michel, J. M.
    Simmonds, M. B.
    Harding, S. A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (03) : 995 - 999
  • [30] Clopidogrel cuts risk of vascular events in patients with acute coronary syndromes
    不详
    FORMULARY, 2001, 36 (05) : 367 - 368
12345